Scientific Update Consulting has, over the last 11 years, been involved as expert witnesses in many court cases (in the US, UK, continental Europe, Asia and Australia) involving patent disputes, mostly between major multinational pharmaceutical companies and generics. The consultants have been appointed as independent witnesses for a number of legal trials in Europe, North American and Asia specifically in cases involving process chemistry, crystallisation and polymoprhism and related issues.
Often it is the multinational pharmaceutical companies that are trying to hold on to exclusivity for their blockbuster patents or to extend the patent life by use of ‘innovative’ process patents or novel solid drug forms. In contrast, the generics are seeking to circumvent these patents, though they also usually make counterclaims regarding validity, often with reasonable justification.
If you have a legal dispute and would be interested in seeking assistance, please contact Scientific Update today, for a completely confidential discussion . Alternatively, use this web site's contact form to contact one of the consultants directly.